Tagged: XOMA

[[tagnumber 0]][[tagnumber 1]]If you check out the official website of XOMA Corp (NASDAQ:XOMA), you will see that it is presented as a late–stage biotech whose portfolio of therapeutic product candidates is primarily based on...

[[tagnumber 0]][[tagnumber 1]]The good thing about biotechs is that a successful clinical trial could send the company flying on the charts. Unfortunately, there is a flip side to it, as well, and it hit...